关注
Brad Urquhart
Brad Urquhart
Physiology & Pharmacology, Western University, London, Ontario, Canada
在 schulich.uwo.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nuclear receptors and the regulation of drug‐metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs
BL Urquhart, RG Tirona, RB Kim
The Journal of Clinical Pharmacology 47 (5), 566-578, 2007
4532007
Pre–B-Cell Colony–Enhancing Factor Regulates NAD+-Dependent Protein Deacetylase Activity and Promotes Vascular Smooth Muscle Cell Maturation
E van der Veer, Z Nong, C O’Neil, B Urquhart, D Freeman, JG Pickering
Circulation research 97 (1), 25-34, 2005
3012005
Human skeletal muscle drug transporters determine local exposure and toxicity of statins
MJ Knauer, BL Urquhart, HE Meyer zu Schwabedissen, UI Schwarz, ...
Circulation research 106 (2), 297-306, 2010
2472010
Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial
L Craven, A Rahman, SN Parvathy, M Beaton, J Silverman, K Qumosani, ...
Official journal of the American College of Gastroenterology| ACG 115 (7 …, 2020
2452020
Blood− brain barrier transporters and response to CNS-active drugs
BL Urquhart, RB Kim
European journal of clinical pharmacology 65, 1063-1070, 2009
2302009
Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets
YJ Lim, NA Sidor, NC Tonial, A Che, BL Urquhart
Toxins 13 (2), 142, 2021
1742021
Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe
BL Urquhart, JA Ware, RG Tirona, RH Ho, BF Leake, UI Schwarz, H Zaher, ...
Pharmacogenetics and genomics 18 (5), 439-448, 2008
1562008
Propofol neuroprotection in cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks
NA Bayona, AW Gelb, Z Jiang, JX Wilson, BL Urquhart, DF Cechetto
The Journal of the American Society of Anesthesiologists 100 (5), 1151-1159, 2004
1432004
Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference
X Zheng, J Koropatnick, M Li, X Zhang, F Ling, X Ren, X Hao, H Sun, ...
The Journal of Immunology 177 (8), 5639-5646, 2006
1412006
Metabolic products of the intestinal microbiome and extremes of atherosclerosis
C Bogiatzi, G Gloor, E Allen-Vercoe, G Reid, RG Wong, BL Urquhart, ...
Atherosclerosis 273, 91-97, 2018
1402018
Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning
SN Dorman, K Baranova, JHM Knoll, BL Urquhart, G Mariani, ...
Molecular oncology 10 (1), 85-100, 2016
1222016
N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes
H Moazzen, X Lu, NL Ma, TJ Velenosi, BL Urquhart, LJ Wisse, ...
Cardiovascular diabetology 13, 1-13, 2014
1112014
Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model
X Zheng, J Koropatnick, D Chen, T Velenosi, H Ling, X Zhang, N Jiang, ...
International journal of cancer 132 (4), 967-977, 2013
1102013
Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis
TJ Velenosi, BL Urquhart
Expert opinion on drug metabolism & toxicology 10 (8), 1131-1143, 2014
802014
Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine
JD Spence, BL Urquhart, H Bang
Nephrology Dialysis Transplantation 31 (6), 937-944, 2016
732016
Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
TJ Velenosi, A Hennop, DA Feere, A Tieu, AS Kucey, P Kyriacou, ...
Scientific Reports 6 (1), 22526, 2016
702016
Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms
BKA Thomson, TD Nolin, TJ Velenosi, DA Feere, MJ Knauer, LJ Asher, ...
American Journal of Kidney Diseases 65 (4), 574-582, 2015
692015
Down-regulation of hepatic CYP3A and CYP2C mediated metabolism in rats with moderate chronic kidney disease
TJ Velenosi, AYN Fu, S Luo, H Wang, BL Urquhart
Drug Metabolism and Disposition 40 (8), 1508-1514, 2012
682012
The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs
BL Urquhart, JC Gregor, N Chande, MJ Knauer, RG Tirona, RB Kim
American Journal of Physiology-Gastrointestinal and Liver Physiology 298 (2 …, 2010
612010
Moderate renal impairment and toxic metabolites produced by the intestinal microbiome: dietary implications
M Pignanelli, C Bogiatzi, G Gloor, E Allen-Vercoe, G Reid, BL Urquhart, ...
Journal of Renal Nutrition 29 (1), 55-64, 2019
592019
系统目前无法执行此操作,请稍后再试。
文章 1–20